Literature DB >> 14119275

VENOUS CONSTRICTION AS THE CAUSE OF INCREASED VASCULAR PERMEABILITY PRODUCED BY 5-HYDROXYTRYPTAMINE, HISTAMINE, BRADYKININ AND 48/80 IN THE RAT.

D A ROWLEY.   

Abstract

Entities:  

Keywords:  BLOOD PRESSURE; BRADYKININ; COMPOUND 48-80; EXPERIMENTAL LAB STUDY; HISTAMINE; PERFUSION; PERMEABILITY; PHARMACOLOGY; RATS; SEROTONIN; VASODILATOR AGENTS; VASOMOTOR SYSTEM; VEINS

Mesh：

Substances：

Year:  1964        PMID： 14119275      PMCID： PMC2094655     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  7 in total

1.  Humoral agents and venous tone. Effects of catecholamines, 5-hydroxytryptamine, histamine, and nitritex.

Authors:  E P SHARPEY-SCHAFER; J GINSBURG
Journal:  Lancet       Date:  1962-12-29       Impact factor: 79.321

2.  Effect of histamine on small and large vessel pressures in the dog foreleg.

Authors:  F J HADDY
Journal:  Am J Physiol       Date:  1960-01

3.  Release of pharmacologically active substances from the rat skin in vivo following thermal injury.

Authors:  M ROCHA E SILVA; S R ROSENTHAL
Journal:  J Pharmacol Exp Ther       Date:  1961-04       Impact factor: 4.030

4.  Autoradiographic observations on the mucous cells of the stomach and intestine.

Authors:  M A JENNINGS; H W FLOREY
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1956-04

5.  The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain.

Authors:  L M MCEWEN
Journal:  J Physiol       Date:  1956-03-28       Impact factor: 5.182

6.  Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study.

Authors:  G MAJNO; G E PALADE
Journal:  J Biophys Biochem Cytol       Date:  1961-12

7.  5-Hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats.

Authors:  D A ROWLEY; E P BENDITT
Journal:  J Exp Med       Date:  1956-04-01       Impact factor: 14.307
  7 in total
  15 in total

1.  THE DELAYED AND PROLONGED VASCULAR LEAKAGE IN INFLAMMATION. I. TOPOGRAPHY OF THE LEAKING VESSELS AFTER THERMAL INJURY.

Authors:  R S COTRAN; G MAJNO
Journal:  Am J Pathol       Date:  1964-08       Impact factor: 4.307

2.  THE DELAYED AND PROLONGED VASCULAR LEAKAGE IN INFLAMMATION. II. AN ELECTRON MICROSCOPIC STUDY OF THE VASCULAR RESPONSE AFTER THERMAL INJURY.

Authors:  R S COTRAN
Journal:  Am J Pathol       Date:  1965-04       Impact factor: 4.307

3.  The effect of anti-inflammatory drugs on vascular smooth muscle.

Authors:  B J Northover
Journal:  Br J Pharmacol Chemother       Date:  1967-11

4.  A perfused vein preparation sensitive to plasma kinins.

Authors:  J D Horowitz; M L Mashford
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1969

5.  Experiences with surgical management of acute gastric mucosal hemorrhage: a unified concept in the pathophysiology.

Authors:  T Drapanas; W C Woolverton; J W Reeder; R L Reed; R F Weichert
Journal:  Ann Surg       Date:  1971-05       Impact factor: 12.969

6.  The mechanism of histamine-induced transcapillary fluid movement.

Authors:  W Dietzel; W H Massion; L B Hinshaw
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

7.  The basis of the histamine assay in human skin: II. Wheal formation.

Authors:  C Carey; M Clark; J A Lopez-Gil; D W Vere
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

Review 8.  Acute inflammation. A review.

Authors:  G B Ryan; G Majno
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

9.  Effect of vagotomy on anaphylaxis in the rat.

Authors:  R M Levy; J E Rose; J S Johnson
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

10.  Effect of bradykinin antagonists on bradykinin-induced plasma extravasation, venoconstriction, prostaglandin E2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit.

Authors:  T Griesbacher; F Lembeck
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.